CytoMed Therapeutics Ltd - GDTC - stock price prediction, stock price target, analyst ratings from 1 analyst

CytoMed Therapeutics Ltd has a share price target of US$ 5, revenue growth forecast of -13.3%, and profit growth estimate of -1.0% for FY25, based on top 1 analyst call.